2-Methyl-1-(2-(1-methylpiperidin-4-yl)phenyl)propan-2-amine, 97%, 100mg

2-Methoxy-5-(trifluoromethoxy)benzoyl chloride, 5g

3-(Trifluoroacetamido)propanoic acid, 98%, 1g

3H-2,1-Benzoxathiol-3-one, 4,5,6,7-tetraiodo-, 1,1-dioxide, 1g

Glycosynthase (Endo-M-N175Q) Recombinant: from Mucor hiemalis expressed in Escherichia coli (100m units/vial)1vial

1-Ethoxycarbonyl-4-piperidone>97.0%(GC)25g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2-(trifluoromethyl)phenyl)butanoic acid, 98%, 100mg

3,6-Dimethylcarbazole>98.0%(GC)5g

6-Methoxysalicylic Acid>98.0%(GC)(T)5g

(R)-tert-Butyl 3-(3-fluoro-2-nitrophenoxy)pyrrolidine-1-carboxylate, 95.0%, 1g

2-((4-Bromophenoxy)methyl)tetrahydro-2H-pyran, 95.0%, 250mg

Diethyl 1-benzylazetidine-3,3-dicarboxylate, 95.0%, 5g

Diisopropylether, min. 98 %, zur Synthese, stab., 2.5 l, Glasverpackung